FDA’s Regulatory Perspective on Individualized Neoantigen‐specific Cancer Vaccines

Speaker Presentation Husain Syed US FDA 2019
FDA’s Regulatory Perspective on Individualized Neoantigen‐specific Cancer Vaccines